MKI67 and breast carcinoma: In evaluating relationships between clinicopathological characteristics and breast cancer subtypes we found that there was an association between subtype and proliferation with Ki67 levels being lower in the luminal A subtype compared to HER2-positive (p < 0.001) and TNBC (p < 0.001), as expected.